Genocea Biosciences, Inc. (GNCAQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST
Genocea Biosciences Revenue
Genocea Biosciences had revenue of $270.00K in the quarter ending March 31, 2022. This brings the company's revenue in the last twelve months to $1.91M, up 40.62% year-over-year. In the year 2021, Genocea Biosciences had annual revenue of $1.64M with 20.75% growth.
Revenue (ttm)
1.91M
Revenue Growth
+40.62%
P/S Ratio
0.00
Revenue / Employee
25.82K
Employees
74
Market Cap
59.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 1.64M | 282.00K | 20.75% |
| Dec 31, 2020 | 1.36M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oriental Bioengineering | 121.58M |
| Infinity Pharmaceuticals | 2.57M |
| Baudax Bio | 1.27M |
| Mymetics | 564.14K |
| Cardax | 500.71K |
| Core One Labs | 338.91K |
| Bioasis Technologies | 199.01K |
| Panacos Pharmaceuticals | 99.00K |